SUPPLEMENTARY INFORMATION S2

Data analysis for whole cell screening
The following variables are then defined as follows: " # is the median of non-excluded raw positive control values, " $ is the median of non-excluded negative control values, " # is the median absolute deviation of positive control values and " $ is the median absolute deviation of negative control values.
As the raw values for negative control is higher than those of positive control, robust signal to baseline and robust Z' factor are calculated as follows:
The percentage effect is calculated as follows:
Dose response curve is calculated using MathIQ model 203 in ActivityBase XE. 27, 28, 29, 32, 33 and 34) . Colours represent the modifications: blue -O-benzyl analogues (e.g. 5); orange -modification on pyrimidine C-4 (e.g. 23); purple -modification on pyrimidine C-5 (e.g. 38); turquoise -modification on pyrimidine C-6 (e.g. 10); red -modification on pyrazole (e. g. 30, 35) ; brown -other modification on pyrimidine core (e.g 11, 12); green -pyridine core (e.g. 45). Original hit 2 is represented by a black diamond. Mean pEC50 (± SD) [a] Compound S. aureus RN4220 (n = 3) S. aureus RN6390 (n = 2) 1 3.6 (± 0.01) 3.7 (± 0.06) 2 3.9 (± 0.05) 4.0 (± 0.02) Table S2 . Changes to the nucleotide pool during ciprofloxacin and trimethoprim treatments.
Log2 fold changes are calculated on the average for each time point compared to an untreated control at 0 hours. T = time in minutes. N = 3 for T90 and T180 timepoints, but N = 26 for T0.
Deoxyguanine and adenine derivatives are isomers and could not be resolved on our platform -their data are therefore duplicated.
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